Henry Schein Inc (HSIC)

$70.64 -0.04 (-0.06%)
Market Cap 8.60B
Revenue (ttm) 12.67B
Net Income (ttm) 390.00M
EPS (ttm) N/A
PE Ratio 15.33
Forward PE 15.10
Profit Margin 3.08%
Debt to Equity Ratio 0.51
Volume 4,111,100
Avg Vol 1,694,716
Day's Range N/A - N/A
Shares Out 121.72M
Stochastic %K 24%
Beta 0.87
Analysts Sell
Price Target $77.00

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PP...

Industry: Medical Distribution
Sector: Healthcare
Phone: 631 843 5500
Address:
135 Duryea Road, Melville, United States
LewisDaKat
LewisDaKat Jul. 14 at 10:25 PM
News HSIC Price Target Alert: $75.00. Issued by Leerink Partners https://marketwirenews.com/news-releases/hsic-price-target-alert-75-00-issued-by-leerink-part-4750681202439977.html $HSIC
0 · Reply
Estimize
Estimize Jul. 14 at 1:01 PM
Wall St is expecting 1.20 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 11:30 AM
Baird updates rating for Henry Schein ( $HSIC ) to Neutral, target set at 82 → 72.
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to In-Line with a price target of 78.
0 · Reply
Estimize
Estimize Jul. 8 at 1:00 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 1:17 PM
$HSIC rose 15.3% in the past year compared to the industry’s 1.1% growth. 📈 Henry Schein One is fueling growth with new solutions and partnerships, while acquisitions like Acentus and R. Weinstein, Inc. are expanding its product lines. However, macroeconomic pressures and fierce competition remain challenges. Opportunity assessment here 👉 https://www.zacks.com/commentary/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-body-820&ADID=SYND_STOCKTWITS_TWEET_2_2565482_BODY_820
0 · Reply
Estimize
Estimize Jul. 7 at 1:00 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 11:19 AM
$HSIC looks strong on digital growth — but is it enough? Henry Schein One is driving optimism, but macro headwinds and intense competition are tough to ignore. Opportunity vs. risk — full breakdown here 👉 https://www.zacks.com/stock/news/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2565482_TEASER
0 · Reply
RunnerSignals
RunnerSignals Jun. 26 at 3:42 AM
Short Squeeze Watch $RMBS $VEEV $VRNA $MASI $HSIC are catching attention with rising trends and shifting short interest. Could a squeeze be brewing? https://stocksrunner.com/news/2025-06-25-13-high-short-interest-stocks-primed-for-a-short-squeeze
1 · Reply
Estimize
Estimize Jun. 23 at 1:03 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on HSIC
Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

Jul 15, 2025, 7:05 AM EDT - 21 hours ago

Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

Jun 2, 2025, 6:45 PM EDT - 6 weeks ago

Updated: Henry Schein to Participate in Upcoming Investor Conference in June

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

May 20, 2025, 6:30 AM EDT - 2 months ago

Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

Henry Schein Post Earnings Review

May 17, 2025, 9:30 AM EDT - 2 months ago

Henry Schein Post Earnings Review

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

May 16, 2025, 4:10 PM EDT - 2 months ago

Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

Henry Schein to Participate in Upcoming Investor Conference in June

May 15, 2025, 6:30 AM EDT - 2 months ago

Henry Schein to Participate in Upcoming Investor Conference in June

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results

May 6, 2025, 9:36 AM EDT - 2 months ago

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results

Henry Schein to Participate in Upcoming Investor Conferences in May

May 6, 2025, 6:30 AM EDT - 2 months ago

Henry Schein to Participate in Upcoming Investor Conferences in May

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

May 5, 2025, 4:26 PM EDT - 2 months ago

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

Henry Schein misses quarterly revenue estimates on weak demand for dental products

May 5, 2025, 8:49 AM EDT - 2 months ago

Henry Schein misses quarterly revenue estimates on weak demand for dental products

Henry Schein Reports First Quarter 2025 Financial Results

May 5, 2025, 6:00 AM EDT - 2 months ago

Henry Schein Reports First Quarter 2025 Financial Results

Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Apr 22, 2025, 6:30 AM EDT - 3 months ago

Henry Schein Medical Announces Winner of Its 2025 Rising Star Award

Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

Apr 8, 2025, 6:30 AM EDT - 3 months ago

Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

Henry Schein Received Validation of Net-Zero Science-Based Targets

Apr 7, 2025, 6:30 AM EDT - 3 months ago

Henry Schein Received Validation of Net-Zero Science-Based Targets

IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Mar 31, 2025, 9:30 AM EDT - 3 months ago

IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor

Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show

Mar 25, 2025, 9:00 AM EDT - 4 months ago

Henry Schein Will Showcase a Selection of the Company's Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show

Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year

Mar 11, 2025, 6:30 AM EDT - 4 months ago

Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year

Henry Schein Looks Bullish (Technical Analysis)

Mar 11, 2025, 4:25 AM EDT - 4 months ago

Henry Schein Looks Bullish (Technical Analysis)

Henry Schein: An Industry Leader That Offers Some Upside From Here

Mar 4, 2025, 5:57 PM EST - 4 months ago

Henry Schein: An Industry Leader That Offers Some Upside From Here

Henry Schein to Participate in Upcoming Investor Conference in March

Mar 3, 2025, 6:30 AM EST - 4 months ago

Henry Schein to Participate in Upcoming Investor Conference in March

Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award

Feb 26, 2025, 6:30 AM EST - 4 months ago

Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award

Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:09 PM EST - 5 months ago

Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript

Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth

Feb 25, 2025, 11:51 AM EST - 5 months ago

Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth

Henry Schein forecasts 2025 profit below estimates on weak demand for dental products

Feb 25, 2025, 8:07 AM EST - 5 months ago

Henry Schein forecasts 2025 profit below estimates on weak demand for dental products

Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance

Feb 25, 2025, 6:00 AM EST - 5 months ago

Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance

Henry Schein Chairman and CEO Stanley M. Bergman Receives National Association of Wholesaler-Distributors Dirk Van Dongen Lifetime Achievement Award

Feb 12, 2025, 6:30 AM EST - 5 months ago

Henry Schein Chairman and CEO Stanley M. Bergman Receives National Association of Wholesaler-Distributors Dirk Van Dongen Lifetime Achievement Award

Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

Feb 10, 2025, 6:30 AM EST - 5 months ago

Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

CL

Japan In The Spotlight; Blockchain In AI's Shadow

Jan 31, 2025, 10:30 PM EST - 5 months ago

Japan In The Spotlight; Blockchain In AI's Shadow

APO BBJP DBJP DFJ DXJ DXJS EWJ

Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance

Jan 29, 2025, 7:00 AM EST - 5 months ago

Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance

KKR

KKR builds stake in Henry Schein, reaches deal for board seats, WSJ reports

Jan 29, 2025, 5:45 AM EST - 5 months ago

KKR builds stake in Henry Schein, reaches deal for board seats, WSJ reports

KKR

Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET

Jan 23, 2025, 6:30 AM EST - 6 months ago

Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET

Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say

Jan 22, 2025, 4:37 PM EST - 6 months ago

Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say

Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein

Jan 16, 2025, 6:42 AM EST - 6 months ago

Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein

Henry Schein Completes Acquisition of Acentus

Jan 15, 2025, 6:30 AM EST - 6 months ago

Henry Schein Completes Acquisition of Acentus

Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles

Jan 14, 2025, 9:25 AM EST - 6 months ago

Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles

Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires

Jan 9, 2025, 6:30 AM EST - 6 months ago

Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires

Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst

Jan 7, 2025, 12:03 PM EST - 6 months ago

Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst

CAH

Henry Schein to Participate at J.P. Morgan's Healthcare Investor Conference

Dec 17, 2024, 6:30 AM EST - 7 months ago

Henry Schein to Participate at J.P. Morgan's Healthcare Investor Conference

Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits

Nov 23, 2024, 7:47 AM EST - 8 months ago

Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits

Henry Schein to Participate in Investor Conferences in December

Nov 21, 2024, 6:30 AM EST - 8 months ago

Henry Schein to Participate in Investor Conferences in December

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Nov 20, 2024, 6:30 AM EST - 8 months ago

Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products

Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

Nov 18, 2024, 1:35 PM EST - 8 months ago

Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits

Nov 18, 2024, 12:36 PM EST - 8 months ago

Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits

Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 9:35 PM EST - 9 months ago

Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

Henry Schein beats quarterly profit estimates on lower costs

Nov 5, 2024, 7:59 AM EST - 9 months ago

Henry Schein beats quarterly profit estimates on lower costs

Henry Schein Reports Third Quarter 2024 Financial Results and Increases 2024 Financial Guidance

Nov 5, 2024, 6:00 AM EST - 9 months ago

Henry Schein Reports Third Quarter 2024 Financial Results and Increases 2024 Financial Guidance

Federman & Sherwood Investigates Henry Schein, Inc. for Data Breach

Oct 24, 2024, 2:21 PM EDT - 9 months ago

Federman & Sherwood Investigates Henry Schein, Inc. for Data Breach

Henry Schein to Participate in Investor Conferences in November

Oct 24, 2024, 6:30 AM EDT - 9 months ago

Henry Schein to Participate in Investor Conferences in November

Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks

Oct 17, 2024, 8:00 AM EDT - 9 months ago

Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks

ZTEK

Henry Schein Opens Customer Assistance Hotline Ahead of Hurricane Milton

Oct 8, 2024, 5:33 PM EDT - 10 months ago

Henry Schein Opens Customer Assistance Hotline Ahead of Hurricane Milton

LewisDaKat
LewisDaKat Jul. 14 at 10:25 PM
News HSIC Price Target Alert: $75.00. Issued by Leerink Partners https://marketwirenews.com/news-releases/hsic-price-target-alert-75-00-issued-by-leerink-part-4750681202439977.html $HSIC
0 · Reply
Estimize
Estimize Jul. 14 at 1:01 PM
Wall St is expecting 1.20 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 11:30 AM
Baird updates rating for Henry Schein ( $HSIC ) to Neutral, target set at 82 → 72.
0 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 1:00 PM
Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to In-Line with a price target of 78.
0 · Reply
Estimize
Estimize Jul. 8 at 1:00 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 1:17 PM
$HSIC rose 15.3% in the past year compared to the industry’s 1.1% growth. 📈 Henry Schein One is fueling growth with new solutions and partnerships, while acquisitions like Acentus and R. Weinstein, Inc. are expanding its product lines. However, macroeconomic pressures and fierce competition remain challenges. Opportunity assessment here 👉 https://www.zacks.com/commentary/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-body-820&ADID=SYND_STOCKTWITS_TWEET_2_2565482_BODY_820
0 · Reply
Estimize
Estimize Jul. 7 at 1:00 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 11:19 AM
$HSIC looks strong on digital growth — but is it enough? Henry Schein One is driving optimism, but macro headwinds and intense competition are tough to ignore. Opportunity vs. risk — full breakdown here 👉 https://www.zacks.com/stock/news/2565482/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2565482-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2565482_TEASER
0 · Reply
RunnerSignals
RunnerSignals Jun. 26 at 3:42 AM
Short Squeeze Watch $RMBS $VEEV $VRNA $MASI $HSIC are catching attention with rising trends and shifting short interest. Could a squeeze be brewing? https://stocksrunner.com/news/2025-06-25-13-high-short-interest-stocks-primed-for-a-short-squeeze
1 · Reply
Estimize
Estimize Jun. 23 at 1:03 PM
Wall St is expecting 1.21 EPS for $HSIC Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/hsic?chart=historical&metric_name=eps&utm_co
0 · Reply
swingingtech
swingingtech Jun. 4 at 9:53 PM
$CIEN $HSIC $RNA https://wallstreetwaves.com/key-wednesday-options-activity-cien-hsic-rna/
0 · Reply
OptionRunners
OptionRunners Jun. 4 at 6:27 PM
$HSIC Seller of the July 18th $75/$80 call spreads 5,000 times for $0.86. Looks to be closing those out for a loss.
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 1:22 PM
Henry Schein ($HSIC) — is the stock a hidden gem or stuck in the mud? 🤔 📊 Henry Schein One's software is driving robust gains amid macroeconomic challenges, with nearly 20% YoY growth in Dentrix Ascend and Dentally subscriptions. 📉 Yet, global macro pressures and fierce competition could weigh on results, although the recent dip in gross profit was due to an increase in cost of sales. Deep dive here 👉 https://www.zacks.com/commentary/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-body&ADID=SYND_STOCKTWITS_TWEET_2_2477016_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 26 at 12:04 PM
Investors are optimistic about $HSIC, owing to the strong performance of its Henry Schein One business. Explore further: https://www.zacks.com/stock/news/2477016/should-you-retain-henry-schein-stock-in-your-portfolio-right-now?cid=sm-stocktwits-2-2477016-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477016_TEASER
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 16 at 8:08 PM
$HSIC closes $250M strategic investment from KKR - now holding 12% of shares. KKR's Dan Daniel joins board as independent director. Cash infusion helps debt concerns, but dilution at $76.10/share raises eyebrows. Market will decide if KKR's operational expertise justifies the equity cost. https://www.sec.gov/Archives/edgar/data/1000228/000119312525121679/d919434d8k.htm
0 · Reply
OptionRunners
OptionRunners May. 12 at 7:16 PM
$HSIC Buyer of the July 18th $75/$80 call spreads 5,000 times for $1.00
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 1:29 PM
Wells Fargo has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Equal-Weight with a target price of 80 → 75.
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 12:30 PM
Barrington Research updates rating for Henry Schein ( $HSIC ) to Outperform, target set at 90 → 86.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:32 AM
$HSIC Henry Schein sees annual run-rate savings at high end of $75M-$100M goal During the first quarter of 2025, the company recorded $25M in restructuring costs and expects to achieve annual run-rate savings at the high end of its $75M-$100M goal by the end of 2025.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:31 AM
$HSIC Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.84 Backs FY25 revenue growth about 2%-4% over 2024, consensus $13.01B. Sees FY25 adjusted EBITDA growth mid-single digits.
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 10:30 AM
$HSIC Henry Schein reports Q1 adjusted EPS $1.15, consensus $1.11 Reports Q1 revenue $3.17B, consensus $3.23B. "We are pleased with our first quarter financial results as well as the momentum we are seeing heading into the second quarter and remain confident in the fundamentals of our business," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "We are advancing our BOLD+1 Strategic Plan, which has been refreshed for 2025 to 2027, with our team focused on growing the distribution business through increasing operational efficiency and enhancing customer experience, growing our dental and medical specialty businesses and corporate brand products, and further developing our digital footprint and digital solutions. We remain committed to our long-term financial goal of high-single-digit to low-double-digit earnings growth by continuing to successfully execute against this strategy," Mr. Bergman added.
0 · Reply